ID   SO1C1_RAT               Reviewed;         716 AA.
AC   Q9EPZ7;
DT   10-JAN-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   29-MAY-2024, entry version 134.
DE   RecName: Full=Solute carrier organic anion transporter family member 1C1;
DE   AltName: Full=BBB-specific anion transporter type 1 {ECO:0000303|PubMed:17667996};
DE            Short=BAST1 {ECO:0000303|PubMed:17667996};
DE   AltName: Full=Blood-brain barrier-specific anion transporter 1;
DE   AltName: Full=Organic anion transporter 1C1;
DE            Short=OATP1C1;
DE   AltName: Full=Organic anion-transporting polypeptide 14 {ECO:0000303|PubMed:18687783};
DE            Short=OATP-14 {ECO:0000303|PubMed:12923172, ECO:0000303|PubMed:17667996, ECO:0000303|PubMed:18687783};
DE   AltName: Full=Solute carrier family 21 member 14;
DE   AltName: Full=Thyroxine transporter;
GN   Name=Slco1c1; Synonyms=Bsat1, Oatp1c1, Oatpf, Slc21a14;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Brain capillary;
RX   PubMed=11149669; DOI=10.1097/00004647-200101000-00008;
RA   Li J.Y., Boado R.J., Pardridge W.M.;
RT   "Blood-brain barrier genomics.";
RL   J. Cereb. Blood Flow Metab. 21:61-68(2001).
RN   [2]
RP   FUNCTION, TRANSPORTER ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=12923172; DOI=10.1074/jbc.m306933200;
RA   Sugiyama D., Kusuhara H., Taniguchi H., Ishikawa S., Nozaki Y.,
RA   Aburatani H., Sugiyama Y.;
RT   "Functional characterization of rat brain-specific organic anion
RT   transporter (Oatp14) at the blood-brain barrier: high affinity transporter
RT   for thyroxine.";
RL   J. Biol. Chem. 278:43489-43495(2003).
RN   [3]
RP   FUNCTION, TRANSPORTER ACTIVITY, TISSUE SPECIFICITY, AND BIOPHYSICOCHEMICAL
RP   PROPERTIES.
RX   PubMed=17667996; DOI=10.1038/sj.jcbfm.9600538;
RA   Chu C., Li J.Y., Boado R.J., Pardridge W.M.;
RT   "Blood-brain barrier genomics and cloning of a novel organic anion
RT   transporter.";
RL   J. Cereb. Blood Flow Metab. 28:291-301(2008).
RN   [4]
RP   TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=18687783; DOI=10.1210/en.2008-0378;
RA   Roberts L.M., Woodford K., Zhou M., Black D.S., Haggerty J.E., Tate E.H.,
RA   Grindstaff K.K., Mengesha W., Raman C., Zerangue N.;
RT   "Expression of the thyroid hormone transporters monocarboxylate
RT   transporter-8 (SLC16A2) and organic ion transporter-14 (SLCO1C1) at the
RT   blood-brain barrier.";
RL   Endocrinology 149:6251-6261(2008).
RN   [5]
RP   FUNCTION, TRANSPORTER ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=19819953; DOI=10.1210/en.2009-0769;
RA   Westholm D.E., Salo D.R., Viken K.J., Rumbley J.N., Anderson G.W.;
RT   "The blood-brain barrier thyroxine transporter organic anion-transporting
RT   polypeptide 1c1 displays atypical transport kinetics.";
RL   Endocrinology 150:5153-5162(2009).
CC   -!- FUNCTION: Mediates the Na(+)-independent high affinity transport of
CC       thyroid hormones at the plasma membrane of brain capillary endothelial
CC       cells (PubMed:12923172, PubMed:17667996, PubMed:19819953). The
CC       transport activity of substrates L-thyroxine (T4) and 3,3',5'-triiodo-
CC       L-thyronine (reverse T3, rT3) is much greater than that of 3,3',5-
CC       triiodo-L-thyronine (T3) (PubMed:12923172, PubMed:17667996,
CC       PubMed:19819953). The prehormone, T4, is the major form in the
CC       circulating blood and is converted to the active form, T3, by the
CC       iodothyronine-deiodinase in peripheral organs (PubMed:12923172). T3
CC       plays an essential role in brain development via binding to specific
CC       nuclear receptors (thyroid hormone receptor) (PubMed:12923172). Also
CC       transports organic anions such as the conjugated steroid 17-beta-
CC       glucuronosyl estradiol (17beta-estradiol 17-O-(beta-D-glucuronate))
CC       (PubMed:12923172, PubMed:17667996, PubMed:19819953). Transports T4 and
CC       estrone-3-sulfate in a pH-insensitive manner (By similarity). May serve
CC       as a drug efflux system at the blood brain barrier (PubMed:12923172,
CC       PubMed:17667996). {ECO:0000250|UniProtKB:Q9NYB5,
CC       ECO:0000269|PubMed:12923172, ECO:0000269|PubMed:17667996,
CC       ECO:0000269|PubMed:19819953, ECO:0000303|PubMed:12923172}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3,3',5'-triiodo-L-thyronine(out) = 3,3',5'-triiodo-L-
CC         thyronine(in); Xref=Rhea:RHEA:71815, ChEBI:CHEBI:57261;
CC         Evidence={ECO:0000269|PubMed:12923172};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-thyroxine(out) = L-thyroxine(in); Xref=Rhea:RHEA:71819,
CC         ChEBI:CHEBI:58448; Evidence={ECO:0000269|PubMed:12923172,
CC         ECO:0000269|PubMed:17667996, ECO:0000269|PubMed:19819953};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-thyroxine sulfate(out) = L-thyroxine sulfate(in);
CC         Xref=Rhea:RHEA:73311, ChEBI:CHEBI:176512;
CC         Evidence={ECO:0000250|UniProtKB:Q9NYB5};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=17beta-estradiol 17-O-(beta-D-glucuronate)(out) = 17beta-
CC         estradiol 17-O-(beta-D-glucuronate)(in); Xref=Rhea:RHEA:72691,
CC         ChEBI:CHEBI:82961; Evidence={ECO:0000269|PubMed:12923172,
CC         ECO:0000269|PubMed:17667996, ECO:0000269|PubMed:19819953};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3,3',5-triiodo-L-thyronine(out) = 3,3',5-triiodo-L-
CC         thyronine(in); Xref=Rhea:RHEA:71811, ChEBI:CHEBI:533015;
CC         Evidence={ECO:0000269|PubMed:12923172};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.18 uM for L-thyroxine {ECO:0000269|PubMed:12923172};
CC         KM=0.72 uM for L-thyroxine {ECO:0000269|PubMed:17667996};
CC         KM=10.3 nM for L-thyroxine {ECO:0000269|PubMed:19819953};
CC         KM=10.7 uM for 17beta-estradiol 17-O-(beta-D-glucuronate)
CC         {ECO:0000269|PubMed:12923172};
CC         KM=6.1 uM for 17beta-estradiol 17-O-(beta-D-glucuronate)
CC         {ECO:0000269|PubMed:17667996};
CC         KM=1.3 uM for 17beta-estradiol 17-O-(beta-D-glucuronate)
CC         {ECO:0000269|PubMed:19819953};
CC         KM=0.76 uM for troglitazone sulfate {ECO:0000269|PubMed:12923172};
CC         KM=1.34 uM for cerivastatin {ECO:0000269|PubMed:12923172};
CC         Vmax=32.1 pmol/min/mg protein with L-thyroxine
CC         {ECO:0000269|PubMed:12923172};
CC         Vmax=67 pmol/min/mg protein with L-thyroxine
CC         {ECO:0000269|PubMed:17667996};
CC         Vmax=93.4 pmol/min/mg protein with 17beta-estradiol 17-O-(beta-D-
CC         glucuronate) {ECO:0000269|PubMed:12923172};
CC         Vmax=73 pmol/min/mg protein with 17beta-estradiol 17-O-(beta-D-
CC         glucuronate) {ECO:0000269|PubMed:17667996};
CC         Vmax=14.5 pmol/min/mg protein with cerivastatin
CC         {ECO:0000269|PubMed:12923172};
CC         Vmax=69.0 pmol/min/mg protein with troglitazone sulfate
CC         {ECO:0000269|PubMed:12923172};
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:12923172,
CC       ECO:0000269|PubMed:18687783}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:18687783}. Note=Expressed in the plasma membranes
CC       of brain capillary endothelial cells. {ECO:0000269|PubMed:12923172}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in cerebral microvessels and
CC       choroid plexus (at protein level) (PubMed:12923172, PubMed:17667996,
CC       PubMed:18687783). Brain-specific (PubMed:12923172, PubMed:17667996).
CC       Not detected in glial cells, kidney, heart, lung, skeletal muscle,
CC       spleen, liver, nor testis (PubMed:12923172, PubMed:17667996).
CC       {ECO:0000269|PubMed:12923172, ECO:0000269|PubMed:17667996,
CC       ECO:0000269|PubMed:18687783}.
CC   -!- SIMILARITY: Belongs to the organo anion transporter (TC 2.A.60) family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF306546; AAG37066.1; -; mRNA.
DR   RefSeq; NP_445893.1; NM_053441.1.
DR   AlphaFoldDB; Q9EPZ7; -.
DR   SMR; Q9EPZ7; -.
DR   BioGRID; 250000; 1.
DR   STRING; 10116.ENSRNOP00000013230; -.
DR   TCDB; 2.A.60.1.10; the organo anion transporter (oat) family.
DR   GlyCosmos; Q9EPZ7; 3 sites, 2 glycans.
DR   GlyGen; Q9EPZ7; 3 sites, 2 N-linked glycans (1 site).
DR   iPTMnet; Q9EPZ7; -.
DR   PhosphoSitePlus; Q9EPZ7; -.
DR   PaxDb; 10116-ENSRNOP00000013230; -.
DR   GeneID; 84511; -.
DR   KEGG; rno:84511; -.
DR   UCSC; RGD:628660; rat.
DR   AGR; RGD:628660; -.
DR   CTD; 53919; -.
DR   RGD; 628660; Slco1c1.
DR   eggNOG; KOG3626; Eukaryota.
DR   InParanoid; Q9EPZ7; -.
DR   OrthoDB; 2874223at2759; -.
DR   PhylomeDB; Q9EPZ7; -.
DR   Reactome; R-RNO-879518; Transport of organic anions.
DR   PRO; PR:Q9EPZ7; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:ARUK-UCL.
DR   GO; GO:0005886; C:plasma membrane; IDA:ARUK-UCL.
DR   GO; GO:0015125; F:bile acid transmembrane transporter activity; IDA:RGD.
DR   GO; GO:0008514; F:organic anion transmembrane transporter activity; ISS:UniProtKB.
DR   GO; GO:0015347; F:sodium-independent organic anion transmembrane transporter activity; IBA:GO_Central.
DR   GO; GO:0015349; F:thyroid hormone transmembrane transporter activity; ISO:RGD.
DR   GO; GO:0015721; P:bile acid and bile salt transport; IDA:RGD.
DR   GO; GO:0006811; P:monoatomic ion transport; IEA:UniProtKB-KW.
DR   GO; GO:2000611; P:positive regulation of thyroid hormone generation; ISO:RGD.
DR   GO; GO:0043252; P:sodium-independent organic anion transport; IBA:GO_Central.
DR   GO; GO:0070327; P:thyroid hormone transport; ISO:RGD.
DR   GO; GO:0055085; P:transmembrane transport; ISO:RGD.
DR   Gene3D; 3.30.60.30; -; 1.
DR   Gene3D; 1.20.1250.20; MFS general substrate transporter like domains; 1.
DR   InterPro; IPR002350; Kazal_dom.
DR   InterPro; IPR036058; Kazal_dom_sf.
DR   InterPro; IPR020846; MFS_dom.
DR   InterPro; IPR036259; MFS_trans_sf.
DR   InterPro; IPR004156; OATP.
DR   NCBIfam; TIGR00805; oat; 1.
DR   PANTHER; PTHR11388; ORGANIC ANION TRANSPORTER; 1.
DR   PANTHER; PTHR11388:SF99; SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY MEMBER 1C1; 1.
DR   Pfam; PF07648; Kazal_2; 1.
DR   Pfam; PF03137; OATP; 1.
DR   SUPFAM; SSF100895; Kazal-type serine protease inhibitors; 1.
DR   SUPFAM; SSF103473; MFS general substrate transporter; 1.
DR   PROSITE; PS51465; KAZAL_2; 1.
DR   PROSITE; PS50850; MFS; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Disulfide bond; Glycoprotein; Ion transport;
KW   Lipid transport; Membrane; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN           1..716
FT                   /note="Solute carrier organic anion transporter family
FT                   member 1C1"
FT                   /id="PRO_0000191057"
FT   TOPO_DOM        1..43
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        44..63
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        64..82
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        83..103
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        104..109
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        110..134
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        135..187
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        188..216
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        217..235
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        236..256
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        257..274
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        275..299
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        300..352
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        353..374
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        375..394
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        395..418
FT                   /note="Helical; Name=8"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        419..422
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        423..446
FT                   /note="Helical; Name=9"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        447..558
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        559..581
FT                   /note="Helical; Name=10"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        582..590
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        591..616
FT                   /note="Helical; Name=11"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        617..650
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        651..668
FT                   /note="Helical; Name=12"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        669..716
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          474..529
FT                   /note="Kazal-like"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00798"
FT   REGION          1..26
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   CARBOHYD        453
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        524
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        537
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        480..510
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00798"
FT   DISULFID        486..506
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00798"
FT   DISULFID        495..527
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00798"
SQ   SEQUENCE   716 AA;  78627 MW;  487734B82A50A6EA CRC64;
     MDTSSKENAH LFHKNSAQPA GGPSFKAGYP STEEARPCCG KLKVFLGALS FVYFAKALTE
     GYLKSTITQI ERRFDIPSSL VGIIDGSFEI GNLLVITFVS YFGAKLHRPK IIGAGCLVMG
     FGTMLIAVPQ FFMEKYSYEK YERYSPSSNL TPNISPCYLE SSSPSPRSIV GKSQNKINDE
     CEVDTSSSMW VYVFLGNLLR GLGETPIQPL GIAYLDDFAS EDNAAFYIGC VQTVAIIGPI
     FGFLLGSLCA KLYVDIGFVN LDHITITPKD PQWVGAWWLG YLIAGFLSLL AAVPFWCLPK
     TLPRSQSRED SGSSSEKSKF ITDDPVNYQM APREESMKIM EMARDFLPSL KSLFRNPVYI
     LYLCASTVQF NSLFGMVTYK PKYIEQQYGQ SSSKANFVIG LINIPAVALG IFSGGIVMKK
     FRLGICEATK LYLGSSVFGY LLFLSLFALG CENSSVAGLT VSYQGTKPVS YHERALFSDC
     NSRCKCSDSK WEPMCGDNGI TYASACLAGC QSSSRSGKNI IFSNCTCVGF AAPKSGNWSG
     MMGRCQKDNG CSQMFLYFLV ISVITSYTLS LGGIPGYILL LRCIQPQLKS FALGIYTLAV
     RVLAGIPAPV YFGVLIDTSC LKWGFKKCGS RGSCRLYDSH AFRHIYLGLT TLLGTVSVFL
     STAVLLVLKK KYVSKRSSFI TAREKIVMSS SVKKETCAAR DHGLQPKYWP GKETRL
//
